New study identifies key gene in development of connections between brain and spinal cordDecember 14, 2005Research released at ACNP Annual Meeting A new study, presented at the American College of Neuropsychopharmacology's (ACNP) Annual Meeting, has identified a specific gene that is necessary for the development of connections between the brain and the spinal cord. This research, conducted by Stanford University through a grant from the National Institutes of Health (NIH), could be critical for future understanding of the development of the human brain and possibly the treatment of spinal cord injuries. During fetal development, genes "instruct" nerve cells on how and where to develop. Researchers examined the plasticity of fetal cells to better understand at what developmental period cells are specialized (i.e., limited in their ability to take on new characteristics) or undifferentiated (i.e., able to be take on new function or characteristics). In attempting to uncover key developmental moments in the brain, the team removed or "knocked out" the gene for Fezl, a DNA-binding protein, to observe its effect on brain development. Mice were used as the animal model because they serve as a powerful genetic representation of human brain circuitry. The major finding of the study was that in developing mice that lack Fezl, normal connections to the spinal cord failed to form. Instead, the brain cells that usually form the spinal cord made inappropriate connections to other parts of the brain. This result led the researchers to determine that Fezl is necessary for proper development of neural connections to the spinal cord. "Normally, Fezl is required for certain brain cells to grow along the pathway that leads into the spinal cord. In the mice lacking the gene for Fezl, this pattern of spinal cord development was not observed," explained senior study author Susan McConnell, Ph.D., Professor of Biological Sciences at Stanford University. "These findings could have important implications in the future treatment of spinal cord injuries." Though these findings have yet to be applied in a clinical setting, it is possible that researchers could utilize the findings about Fezl in stem cell research attempting to stimulate neuron growth to the spinal cord in injured adults. This protein and the gene that controls its production could be essential in understanding how to regenerate connections to the spinal cord that are severed during injury, which results in paralysis. "The discovery of Fezl is a critical finding in unlocking the intricacies of human brain development," noted McConnell. "However, there is still much research to be done in identifying the key target genes in the brain. Fezl is another critical step in piecing together a complete picture of brain and spinal cord development." GYMR |
|||||||||||||||||||||
| Related Spinal Cord Current Events and Spinal Cord News Articles Drug studied as possible treatment for spinal injuries Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed. Scripps research scientists find new link between insulin and core body temperature A team led by scientists at The Scripps Research Institute have discovered a direct link between insulin-a hormone long associated with metabolism and metabolic disorders such as diabetes-and core body temperature. UCI embryonic stem cell therapy restores walking ability in rats with neck injuries The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage. Findings show nanomedicine promising for treating spinal cord injuries Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident. Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility. Researchers identify drug candidate for treating spinal muscular atrophy A chemical cousin of the common antibiotic tetracycline might be useful in treating spinal muscular atrophy (SMA), a currently incurable disease that is the leading genetic cause of death in infants. Master regulator found for regenerating nerve fibers in live animals Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems. Researchers find ways to encourage spinal cord regeneration after injury Animal research is suggesting new ways to aid recovery after spinal cord injury. New studies demonstrate that diet affects recovery rate and show how to make stem cell therapies safer for spinal injury patients. MIT: Muscle 'synergies' may be key to stroke treatment Researchers at MIT and San Camillo Hospital in Venice, Italy, have shown that motor impairments in stroke patients can be understood as impairments in specific combinations of muscle activity, known as synergies. Compound shows potential for slowing progression of ALS A chemical cousin of a drug currently used to treat sepsis dramatically slows the progression of amyotrophic lateral sclerosis, better known as ALS or Lou Gehrig's disease, in mice. More Spinal Cord Current Events and Spinal Cord News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||